Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin

James Brown, Alex C. Conner, Janet E. Digby, Kenya L. Ward, Manjunath Ramanjaneya, Harpal S. Randeva, Simon J. Dunmore

Research output: Contribution to journalArticle

Abstract

Obesity is an established risk factor for type 2 diabetes. Activation of the adiponectin receptors has a clear role in improving insulin resistance although conflicting evidence exists for its effects on pancreatic beta-cells. Previous reports have identified both adiponectin receptors (ADR-1 and ADR-2) in the beta-cell. Recent evidence has suggested that two distinct regions of the adiponectin molecule, the globular domain and a small N-terminal region, have agonist properties. This study investigates the effects of two agonist regions of adiponectin on insulin secretion, gene expression, cell viability and cell signalling in the rat beta-cell line BRIN-BD11, as well as investigating the expression levels of adiponectin receptors (ADRs) in these cells. Cells were treated with globular adiponectin and adiponectin (15-36) +/-leptin to investigate cell viability, expression of key beta-cell genes and ERK1/2 activation. Both globular adiponectin and adiponectin (15-36) caused significant ERK1/2 dependent increases in cell viability. Leptin co-incubation attenuated adiponectin (15-36) but not globular adiponectin induced cell viability. Globular adiponectin, but not adiponectin (15-36), caused a significant 450% increase in PDX-1 expression and a 45% decrease in LPL expression. ADR-1 was expressed at a higher level than ADR-2, and ADR mRNA levels were differentially regulated by non-esterified fatty acids and peroxisome-proliferator-activated receptor agonists. These data provide evidence of roles for two distinct adiponectin agonist domains in the beta-cell and confirm the potentially important role of adiponectin receptor agonism in maintaining beta-cell mass.
LanguageEnglish
Pages944-949
Number of pages6
JournalPeptides
Volume31
Issue number5
Early online date13 Feb 2010
DOIs
Publication statusPublished - May 2010

Fingerprint

Adiponectin Receptors
Adiponectin
Gene expression
Cell Survival
Cells
Gene Expression
Leptin
Chemical activation
Insulin
Cell signaling
Peroxisome Proliferator-Activated Receptors
Insulin-Secreting Cells
Medical problems
Type 2 Diabetes Mellitus
Insulin Resistance
Rats
Fatty Acids
Obesity
Genes

Keywords

  • adiponectin
  • animals
  • cell line
  • cell survival
  • enzyme-linked immunosorbent assay
  • nonesterified fatty acids
  • insulin-secreting cells
  • leptin
  • mitogen-activated protein kinase 1
  • mitogen-activated protein kinase 3
  • peroxisome proliferator-activated receptors
  • rats
  • adiponectin receptors
  • peptide
  • beta-cell
  • cell viability
  • LPL
  • PDX-1

Cite this

Brown, J., Conner, A. C., Digby, J. E., Ward, K. L., Ramanjaneya, M., Randeva, H. S., & Dunmore, S. J. (2010). Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin. Peptides, 31(5), 944-949. https://doi.org/10.1016/j.peptides.2010.02.004
Brown, James ; Conner, Alex C. ; Digby, Janet E. ; Ward, Kenya L. ; Ramanjaneya, Manjunath ; Randeva, Harpal S. ; Dunmore, Simon J. / Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin. In: Peptides. 2010 ; Vol. 31, No. 5. pp. 944-949.
@article{fa808e4ae31a4c3faab865a9d81515c7,
title = "Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin",
abstract = "Obesity is an established risk factor for type 2 diabetes. Activation of the adiponectin receptors has a clear role in improving insulin resistance although conflicting evidence exists for its effects on pancreatic beta-cells. Previous reports have identified both adiponectin receptors (ADR-1 and ADR-2) in the beta-cell. Recent evidence has suggested that two distinct regions of the adiponectin molecule, the globular domain and a small N-terminal region, have agonist properties. This study investigates the effects of two agonist regions of adiponectin on insulin secretion, gene expression, cell viability and cell signalling in the rat beta-cell line BRIN-BD11, as well as investigating the expression levels of adiponectin receptors (ADRs) in these cells. Cells were treated with globular adiponectin and adiponectin (15-36) +/-leptin to investigate cell viability, expression of key beta-cell genes and ERK1/2 activation. Both globular adiponectin and adiponectin (15-36) caused significant ERK1/2 dependent increases in cell viability. Leptin co-incubation attenuated adiponectin (15-36) but not globular adiponectin induced cell viability. Globular adiponectin, but not adiponectin (15-36), caused a significant 450{\%} increase in PDX-1 expression and a 45{\%} decrease in LPL expression. ADR-1 was expressed at a higher level than ADR-2, and ADR mRNA levels were differentially regulated by non-esterified fatty acids and peroxisome-proliferator-activated receptor agonists. These data provide evidence of roles for two distinct adiponectin agonist domains in the beta-cell and confirm the potentially important role of adiponectin receptor agonism in maintaining beta-cell mass.",
keywords = "adiponectin, animals, cell line, cell survival, enzyme-linked immunosorbent assay, nonesterified fatty acids, insulin-secreting cells, leptin, mitogen-activated protein kinase 1, mitogen-activated protein kinase 3, peroxisome proliferator-activated receptors, rats, adiponectin receptors, peptide, beta-cell, cell viability, LPL, PDX-1",
author = "James Brown and Conner, {Alex C.} and Digby, {Janet E.} and Ward, {Kenya L.} and Manjunath Ramanjaneya and Randeva, {Harpal S.} and Dunmore, {Simon J.}",
note = "Copyright (c) 2010 Elsevier Inc. All rights reserved.",
year = "2010",
month = "5",
doi = "10.1016/j.peptides.2010.02.004",
language = "English",
volume = "31",
pages = "944--949",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier",
number = "5",

}

Brown, J, Conner, AC, Digby, JE, Ward, KL, Ramanjaneya, M, Randeva, HS & Dunmore, SJ 2010, 'Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin' Peptides, vol. 31, no. 5, pp. 944-949. https://doi.org/10.1016/j.peptides.2010.02.004

Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin. / Brown, James; Conner, Alex C.; Digby, Janet E.; Ward, Kenya L.; Ramanjaneya, Manjunath; Randeva, Harpal S.; Dunmore, Simon J.

In: Peptides, Vol. 31, No. 5, 05.2010, p. 944-949.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Regulation of beta-cell viability and gene expression by distinct agonist fragments of adiponectin

AU - Brown, James

AU - Conner, Alex C.

AU - Digby, Janet E.

AU - Ward, Kenya L.

AU - Ramanjaneya, Manjunath

AU - Randeva, Harpal S.

AU - Dunmore, Simon J.

N1 - Copyright (c) 2010 Elsevier Inc. All rights reserved.

PY - 2010/5

Y1 - 2010/5

N2 - Obesity is an established risk factor for type 2 diabetes. Activation of the adiponectin receptors has a clear role in improving insulin resistance although conflicting evidence exists for its effects on pancreatic beta-cells. Previous reports have identified both adiponectin receptors (ADR-1 and ADR-2) in the beta-cell. Recent evidence has suggested that two distinct regions of the adiponectin molecule, the globular domain and a small N-terminal region, have agonist properties. This study investigates the effects of two agonist regions of adiponectin on insulin secretion, gene expression, cell viability and cell signalling in the rat beta-cell line BRIN-BD11, as well as investigating the expression levels of adiponectin receptors (ADRs) in these cells. Cells were treated with globular adiponectin and adiponectin (15-36) +/-leptin to investigate cell viability, expression of key beta-cell genes and ERK1/2 activation. Both globular adiponectin and adiponectin (15-36) caused significant ERK1/2 dependent increases in cell viability. Leptin co-incubation attenuated adiponectin (15-36) but not globular adiponectin induced cell viability. Globular adiponectin, but not adiponectin (15-36), caused a significant 450% increase in PDX-1 expression and a 45% decrease in LPL expression. ADR-1 was expressed at a higher level than ADR-2, and ADR mRNA levels were differentially regulated by non-esterified fatty acids and peroxisome-proliferator-activated receptor agonists. These data provide evidence of roles for two distinct adiponectin agonist domains in the beta-cell and confirm the potentially important role of adiponectin receptor agonism in maintaining beta-cell mass.

AB - Obesity is an established risk factor for type 2 diabetes. Activation of the adiponectin receptors has a clear role in improving insulin resistance although conflicting evidence exists for its effects on pancreatic beta-cells. Previous reports have identified both adiponectin receptors (ADR-1 and ADR-2) in the beta-cell. Recent evidence has suggested that two distinct regions of the adiponectin molecule, the globular domain and a small N-terminal region, have agonist properties. This study investigates the effects of two agonist regions of adiponectin on insulin secretion, gene expression, cell viability and cell signalling in the rat beta-cell line BRIN-BD11, as well as investigating the expression levels of adiponectin receptors (ADRs) in these cells. Cells were treated with globular adiponectin and adiponectin (15-36) +/-leptin to investigate cell viability, expression of key beta-cell genes and ERK1/2 activation. Both globular adiponectin and adiponectin (15-36) caused significant ERK1/2 dependent increases in cell viability. Leptin co-incubation attenuated adiponectin (15-36) but not globular adiponectin induced cell viability. Globular adiponectin, but not adiponectin (15-36), caused a significant 450% increase in PDX-1 expression and a 45% decrease in LPL expression. ADR-1 was expressed at a higher level than ADR-2, and ADR mRNA levels were differentially regulated by non-esterified fatty acids and peroxisome-proliferator-activated receptor agonists. These data provide evidence of roles for two distinct adiponectin agonist domains in the beta-cell and confirm the potentially important role of adiponectin receptor agonism in maintaining beta-cell mass.

KW - adiponectin

KW - animals

KW - cell line

KW - cell survival

KW - enzyme-linked immunosorbent assay

KW - nonesterified fatty acids

KW - insulin-secreting cells

KW - leptin

KW - mitogen-activated protein kinase 1

KW - mitogen-activated protein kinase 3

KW - peroxisome proliferator-activated receptors

KW - rats

KW - adiponectin receptors

KW - peptide

KW - beta-cell

KW - cell viability

KW - LPL

KW - PDX-1

UR - http://www.scopus.com/inward/record.url?scp=77951256496&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2010.02.004

DO - 10.1016/j.peptides.2010.02.004

M3 - Article

VL - 31

SP - 944

EP - 949

JO - Peptides

T2 - Peptides

JF - Peptides

SN - 0196-9781

IS - 5

ER -